Laser Therapy in Oncology – ASA MLS® Technology Presented at Medicana Sarajevo
Modern oncology is not only about treating cancer. An equally important aspect of patient care is managing the side effects of chemotherapy and radiotherapy while maintaining quality of life throughout treatment.
Đaković d.o.o. held a professional presentation at Medicana Hospital in Sarajevo, Bosnia and Herzegovina, introducing the potential applications of advanced laser technology developed by the Italian manufacturer ASA Laser.
Laser therapy in oncology is an emerging area of supportive cancer care, particularly through photobiomodulation (PBM), a non-invasive approach that uses controlled light energy to influence biological processes in tissues.
ASA MLS® – What Makes This Laser Technology Different?
Italian manufacturer ASA Laser developed MLS® (Multiwave Locked System), a patented technology that combines synchronized laser emissions with different characteristics.
Unlike many conventional therapeutic lasers, MLS® technology uses a specific method of delivering laser energy with controlled treatment parameters.
Its potential applications extend across several medical fields, including physical therapy, rehabilitation and selected areas of supportive oncology.
These possibilities were the focus of the presentation at Medicana Sarajevo.
Laser Therapy in Oncology – Supporting Patients During Cancer Treatment
Patients undergoing chemotherapy and radiotherapy may experience complications that significantly affect their comfort, mobility and daily activities.
Photobiomodulation is used or being evaluated as a complementary approach for managing certain treatment-related complications, depending on the clinical indication and treatment protocol.
Radiodermatitis – Skin Reactions Caused by Radiotherapy
Radiotherapy may cause redness, irritation, pain and skin damage.
Photobiomodulation is one of the approaches being explored to help prevent or alleviate certain radiation-induced skin reactions.
Peripheral Neuropathy Following Chemotherapy
Some chemotherapy drugs may cause tingling, numbness, pain and reduced sensation in the hands and feet.
These symptoms can sometimes persist long after cancer treatment has ended.
The application of ASA MLS® technology in this area represents one of the developing fields of laser therapy in supportive oncology.
Oral Mucositis – Painful Inflammation of the Oral Mucosa
Certain cancer treatments can cause painful inflammation and damage to the lining of the mouth, making eating, drinking and speaking difficult.
Photobiomodulation is included in specific clinical protocols for the prevention of oral mucositis.
For this application, it is essential to use a suitable medical device, appropriate treatment parameters and established clinical protocols. Not every therapeutic laser is intended for this indication.
European MDR Certification – An Important Medical Device Standard
Alongside technological innovation, regulatory compliance is an important consideration when selecting medical equipment.
Certain ASA Laser systems hold EU MDR certification under Regulation (EU) 2017/745, which establishes requirements for the safety, performance and clinical evaluation of medical devices.
For healthcare institutions, this provides an important basis for assessing medical technology before introducing it into clinical practice.
MDR certification applies to specific devices and their declared intended purposes. The approved indications of each model must therefore be verified individually.
ASA Laser Presentation at Medicana Hospital in Sarajevo
During the professional presentation at Medicana Sarajevo, we introduced the potential applications of ASA MLS® technology in supportive cancer care.
Particular attention was given to photobiomodulation, its potential role in managing certain side effects of cancer treatment, and the importance of appropriate patient selection and treatment protocols.
Such presentations provide healthcare professionals with opportunities to explore medical technologies, exchange knowledge and consider their possible integration into multidisciplinary patient care.
Laser therapy in oncology does not replace chemotherapy, radiotherapy or other established cancer treatments. Its potential role is complementary and requires appropriate clinical assessment and supervision by the treating medical team.
Modern Oncology Is Also About Quality of Life
For patients undergoing demanding cancer treatments, even reducing everyday discomfort can make a meaningful difference.
This is why progress in oncology is increasingly measured not only by advances in treating the disease itself, but also by improvements in supportive care.
Laser therapy in oncology represents one of the areas offering additional possibilities for patient support.
By presenting ASA MLS® technology at Medicana Hospital in Sarajevo, Đaković continues to introduce healthcare professionals in Bosnia and Herzegovina to advanced medical technologies and their potential clinical applications.
Because modern cancer care is not only about fighting the disease, but also about protecting patients’ quality of life throughout treatment.
Learn more about this technology on the ASA
